Order-of-magnitude gap: the company is already serving a demand source whose scale dwarfs its own current business
The model's full reasoning — Q2 2016 call → NOWe need to determine if management describes a mismatch of scale between the company and the demand it is already serving. The key is: management conveys that the company is currently inside something enormous relative to its own size, and that even a small share would make it several times bigger. Also, management must draw the size contrast explicitly. Let's review the transcript. The company is Cognex, a machine vision company. They discuss various markets: consumer electronics, logistics, automotive, etc. They talk about growth rates, but do they describe a specific situation where they are already inside a huge flow and note how small their share is? Look for phrases like "we are only scratching the surface", "we have a small share of a large market", "our revenue is tiny compared to the opportunity", etc. In the transcript, management discusses logistics: "We've seen substantial pick up in our logistics business... we're seeing strong growth and adoption... we're moving well up into the main part of the S curve." They talk about the market being large, but do they explicitly say that their current revenue is a tiny fraction of the total spend? They mention that they expect to grow at 30% in logistics, but they don't explicitly contrast their size with the total market size. They also discuss consumer electronics: "We have a lot of great experience... there's plenty of demand out there." But again, no explicit size contrast. They discuss the mobile terminal market: "We size it as a $500 million market... we expect to bring significant change... early adopters... first volume order from a new customer... relatively small order of around $100,000 initially... not particularly material to this year." That is a case where they are already inside a market (mobile terminals) with a product shipping, and they note the market is $500 million, but their current revenue from it is tiny. However, they say it's not material to this year, and they are just starting. Is that a mismatch of scale? They are already inside it, but they haven't captured much. But do they explicitly say that even a modest share would make them several times bigger? They say the market is $500 million, and their current revenue from it is negligible. But they don't explicitly draw the contrast that a small share would make them several times bigger.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| CRGO | Freightos Limited | Q1 2024 | 2024-05-20 | C+ |
| WRBY | Warby Parker Inc. | Q1 2024 | 2024-05-09 | A |
| LTRX | Lantronix, Inc. | Q3 2024 | 2024-04-29 | C |
| DASH | DoorDash, Inc. | Q3 2023 | 2023-11-01 | C+ |
| ADPT | Adaptive Biotechnologies Corporation | Q4 2022 | 2023-02-14 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| GDRX | GoodRx Holdings, Inc. | Q2 2022 | 2022-08-08 | F |
| FLYW | Flywire Corporation | Q1 2022 | 2022-05-14 | B+ |
| IRTC | iRhythm Technologies, Inc. | Q1 2022 | 2022-05-07 | C+ |
| HROW | Harrow Health, Inc. | Q4 2021 | 2022-03-10 | C |
| RELY | Remitly Global, Inc. | Q4 2021 | 2022-03-02 | B |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| HSTM | HealthStream, Inc. | Q3 2017 | 2017-10-24 | C |
HROW · Q4 2021 → YESThe question is about whether management describes a MISMATCH OF SCALE between the company and the demand it is already serving. Specifically, the company is currently supplying something enormous rel...YES The transcript shows management describing Harrow as already inside the large cataract surgery market (4.5–6 million procedures annually) with real, present-tense participation: thousands of customer relationships, shipping north of two million sterile ophthalmic units last year, and touching roughly one million cataract surgeries. They explicitly contrast this scale against 2021 revenues of $72.5 million, noting that even a modest share of the pass-through-eligible market (1 million procedures × premium pricing) would produce “a big number” and drive revenues “more than double” in the near term. They treat the current business as only the “earliest sliver” of what they are already positioned inside, with the binding question being how much of the existing flow they can capture rather than whether the flow exists. This meets both criteria. The answer is YES. The transcript shows management describing Harrow as already inside the large cataract surgery market (4.
WRBY · Q1 2024 → YESThe question is about whether management describes a MISMATCH OF SCALE between the company and the demand it is already serving. Specifically, the company is currently supplying something enormous rel...YES The transcript explicitly states that the company is already inside the optical industry with real business (245 stores serving customers, 83% of stores offering exams, 2.36 million active customers, and growing revenue from glasses, contacts, and exams). Management then draws the size contrast directly, noting that even the longer 900-store target "would still represent a small fraction of the 45,000 optical shops in the U.S." and that over 50% of major metro areas have only one store.
HSTM · Q3 2017 → YESThe question is about whether management describes a MISMATCH OF SCALE between the company and the demand it is already serving. Specifically, the company is currently supplying something enormous rel...**YES** Management describes the company already being inside a much larger flow of activity (the 80 million-person healthcare workforce, of which 4.6 million are in post-acute settings) and explicitly treats the scale mismatch as the central point. They note their strong sales team is already a “steady contributor” to 4.